Your fact-checks will appear here
Clinical trial
No available sources show that Neuralink or another Elon Musk company has developed a treatment for stress urinary incontinence (SUI). Neuralink’s public materials reference neurotechnology and clinic...
Reported links between Elon Musk and a urinary‑incontinence device in news and social posts point to neuromodulation implants developed by established medtech firms—primarily Neuspera and Medtronic—ra...
Over the past five years, two interlocking forces have driven patient access to sacral neuromodulation (SNM): a flurry of FDA device approvals that expanded the available implants and indications, and...
Existing treatments for urinary incontinence range from conservative measures (pelvic floor training and bladder retraining) to drugs, injectable bulking agents, slings and sacral neuromodulation; sac...
Neurocept appears in commercial supplement/product listings and on its own websites claiming manufacture in an “FDA-registered” or “FDA-approved” facility, but available reporting and regulatory datab...
Available reporting and Neuralink’s own public materials show the company focusing its early human trials on restoring function for people with paralysis and other central nervous system targets — not...